PROTAC Bcl-2 degrader 1

N/A

Report date: 2022/12/28 17:49:53
NME

Base Information

Drug NamePROTAC Bcl-2 degrader 1
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionApoptosis regulator Bcl-2 degraders
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDalian University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesDalian University Of Technology
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A